Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 202

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Long‐acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta‐analysis

Monami, M., Marchionni, N., Mannucci, E. · 2009 · Diabetes, Obesity and Metabolism

Abstract

Aim: Basal insulin in type 1 diabetes can be provided using either NPH (Neutral Protamine Hagedorn) human insulin or long‐acting insulin analogues, which are supposed to warrant a better metabolic control with reduced hypoglycaemic risk. Aim of this meta‐analysis is the assessment of differences with respect to HbA1c (Glycated hemoglobin), incidence of hypoglycaemia, and weight gain, between NPH human insulin and each long‐acting analogue. Methods: Of 285 randomized controlled trials with a duration > 12 weeks comparing long‐acting insulin analogues (detemir or glargine) with NPH insulin in type 1 diabetic patients identified through Medline search and searches on www.clinicaltrials.gov , 20 met eligibility criteria (enrolling 3693 and 2485 in the long‐acting analogues and NPH group respectively). Data on HbA1c and body mass index at endpoint, and incidence of any, nocturnal and severe hypoglycaemia, were extracted and meta‐analysed. Results: Long‐acting analogues had a small, but significant effect on HbA1c [‐0.07 (−0.13; −0.01)%; p = 0.026], in comparison with NPH human insulin. When analysing the effect of long‐acting analogues on body weight, detemir was associated with a significantly smaller weight gain than human insulin [by 0.26 (0.06;0.47) kg/m 2 ; p = 0.012]. Long‐acting analogues were associated with a reduced risk for nocturnal and severe hypoglycaemia [OR (Odd Ratio, 95% Confidence Intervals) 0.69 (0.55; 0.86), and OR 0.73 (0.60; 0.89) respectively; all p < 0.01]. Conclusions: The switch from NPH to long‐acting analogues as basal insulin replacement in type 1 diabetic patients had a small effect on HbA1c, and also reduced the risk of nocturnal and severe hypoglycaemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2008.00976.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 202

Metadata

Authors
Monami, M., Marchionni, N., & Mannucci, E.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2009-02-24
Volume
11
Issue
4
Pages
372-378
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2072040332
Cited by
202
References
6
FWCI
4.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta‐analysis. https://app.cochat.ai/papers/10.1111/j.1463-1326.2008.00976.x
The paper
Monami, M., Marchionni, N., & Mannucci, E. (2009). Long‐acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta‐analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2008.00976.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.